E-mail: Jaroslav.Polak@uhkt.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- CAN ESTIMATION OF WT-1 IN PERIPHERAL BLOOD HELP US IN MONITORING RESIDUAL DISEASE OF PML/RARA-POSITIVE AML PATIENTS?
- Dôležitost fyzioterapie pri nádorovom ochorení prsníka.
- Expression Analysis of WT1 Splicing Variants In CML and AML: –5/+KTS as a Novel Candidate for Early Marker of Relapse
- EXPRESSION LEVELS OF WT1 AND NPM1 AND NOVEL NONSPECIFIC MARKERS AS TOOLS FOR EVALUATING MINIMAL RESIDUAL DISEASE IN AML
- Expression of Four Major WT1 Splicing Variants in AML and CML: Development of Quantitative Real-Time PCRs and Preliminary Results in Patient Samples
- EXPRESSION OF WT-1 IN HUMAN ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
- EXPRESSION OF WT-1, PRAME, RHAMM AND BAALC GENES IN PERIPHERAL BLOOD OF AML PATIENTS AT DIAGNOSIS
- High Cereblon Expression In Lower Risk Myelodysplastic Syndromes With 5q Deletion Is Associated With The Efficacy Of Lenalidomide
- HIGH LEVELS OF CEREBLON MESSENGER RNA ARE THE CHARACTERISTIC FEATURE OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH 5Q DELETION AND ARE CONNECTED WITH THE EFFICACY OF LENALIDOMIDE
- MONITORING OF MRD BY NPM1 MUTATIONS FROM MRNA AND GENOMIC DNA AND ITS COMPARISON WITH EXPRESSION OF WT1 GENE IN AML PATIENTS
- MONITORING OF MRD IN PERIPHERAL BLOOD OF AML PATIENTS BY QUANTITATIVE ESTIMATION OF WT-1 LEVEL
- QUANTITATIVE MONITORING OF WT1 GENE EXPRESSION IN PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA - AN USEFUL TOOL FOR EARLY DETECTION OF MINIMAL RESIDUAL DISEASE
- Real-Time Quantitative PCR (RQ-PCR) Detection of Minimal Residual Disease (MRD) by Optimized WT1 Assay To Enhance Risk Stratification in Acute Myeloid Leukemia (AML): A European LeukemiaNet Study.
- SHORT WT1 VARIANT OF WILMS TUMOR GENE IS EXPRESSED IN LEUKEMIC CELL LINES, PATIENTS WITH AML, MDS AND IN CML BLAST CRISIS
- THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
- Uplatnění genomiky (molekulární genetiky) v onkohematologii
